India is entering into lockdown and there’s hope of developing new mRNA vaccines against emerging regional variants of SARS-CoV-2 like B.1.617. Eterna has launched a design lab to create a superfolder mRNA encoding the “S-2P” spike protein for the B.1.617 variant and raising funds to experimentally test the stability and potency of the top-ranked solutions here at Stanford. Come join us at Eterna.
